Influx Healthtech Limited (NSE:INFLUX)
India · Delayed Price · Currency is INR 203.00
+8.25 (4.24%)
At close: Jan 22, 2026
Influx Healthtech Revenue
Influx Healthtech had revenue of 333.82M INR in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 1.24B. In the fiscal year ending March 31, 2025, Influx Healthtech had annual revenue of 1.05B with 4.89% growth.
Revenue (ttm)
1.24B
Revenue Growth
+4.89%
P/S Ratio
3.80
Revenue / Employee
7.58M
Employees
163
Market Cap
4.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.05B | 48.89M | 4.89% |
| Mar 31, 2024 | 999.65M | 239.09M | 31.44% |
| Mar 31, 2023 | 760.57M | 168.55M | 28.47% |
| Mar 31, 2022 | 592.02M | - | - |
| Mar 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bajaj HealthCare | 6.11B |
| Aarey Drugs & Pharmaceuticals | 4.28B |
| NGL Fine-Chem | 4.08B |
| Infinium Pharmachem | 1.57B |
| Anlon Healthcare | 1.44B |
| Kimia Biosciences | 1.26B |
| Smruthi Organics | 1.20B |
| Shree Ganesh Remedies | 1.06B |